Strata Critical Medical, Inc. Class A Common Stock

Strata Critical Medical (Nasdaq: SRTA) announced it will release fourth quarter 2025 financial results on March 3, 2026, followed by a conference call at 8:00 am ET hosted by Co-CEOs Will Heyburn and Melissa Tomkiel. The company is a time-critical logistics and medical services provider specializing in organ transplant networks and surgical servi...

Strata Critical Medical has appointed Will Cook, President and CEO of Vail Health, to its Board of Directors. Cook brings extensive healthcare leadership experience from roles at University of Colorado Hospital, UPMC, and Johns Hopkins Health System.

Strata Critical Medical outlined its growth strategy at its 2025 Investor Day, targeting high-teens organic Adjusted EBITDA growth and planning $200 million in potential acquisitions through 2029 in the transplant industry logistics market.

Strata Critical Medical, a time-critical logistics and medical services provider, announced its acquisition of Keystone Perfusion to expand its organ recovery platform. The acquisition is expected to generate approximately $65 million in revenue and $13 million in Adjusted EBITDA for the full year 2025.

Strata Critical Medical has acquired Keystone Perfusion Services for $124 million, expanding its medical services platform and creating a comprehensive organ transplant service provider with capabilities in surgical recovery, logistics, and perfusion services.